Search by Drug Name or NDC
NDC 50201-4212-00 Top Value Effervescent Pain Relief 1000; 325; 1916 mg/1; mg/1; mg/1 Details
Top Value Effervescent Pain Relief 1000; 325; 1916 mg/1; mg/1; mg/1
Top Value Effervescent Pain Relief is a ORAL TABLET, EFFERVESCENT in the HUMAN OTC DRUG category. It is labeled and distributed by Tower Laboratories Ltd. The primary component is ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE.
Product Information
| NDC | 50201-4212 |
|---|---|
| Product ID | 50201-4212_f0466c5c-f3f7-e95e-e053-2a95a90ace9d |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Top Value Effervescent Pain Relief |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Apirin, Citric Acid, Sodium Bicarbonate |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, EFFERVESCENT |
| Route | ORAL |
| Active Ingredient Strength | 1000; 325; 1916 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE |
| Labeler Name | Tower Laboratories Ltd |
| Pharmaceutical Class | Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Ac |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part343 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50201-4212-00 (50201421200)
| NDC Package Code | 50201-4212-0 |
|---|---|
| Billing NDC | 50201421200 |
| Package | 10 POUCH in 1 CARTON (50201-4212-0) / 2 TABLET, EFFERVESCENT in 1 POUCH |
| Marketing Start Date | 2014-08-19 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |